Latest updates, from us and our ventures
Q4 2019
BlueRock will be at the @American_Heart Association tomorrow! Hear about breakthroughs and new discoveries in cardi… https://t.co/HHidEpFuPf
— BlueRock (@BlueRockTx) November 15, 2019
We’re excited to partner with @dewpoint_tx to focus on biomolecular condensates, particularly in cardiovascular dis… https://t.co/mTniOmMH5Z
— Leaps by Bayer (@LeapsByBayer) November 14, 2019
At BlueRock, we passionately believe in our science and are steadfast in our commitment to advance cutting-edge cel… https://t.co/zMwDWlm8md
— BlueRock (@BlueRockTx) November 14, 2019
‘The future is faster than you think’ – Thanks to @PeterDiamandis for presenting the fourth #LeapsTalk of the year… https://t.co/ceDnQ3A9jN
— Leaps by Bayer (@LeapsByBayer) November 13, 2019
50 years after #genetherapy was first proposed, it’s being considered a promising treatment option for several huma… https://t.co/K48c58nsz6
— BlueRock (@BlueRockTx) November 11, 2019
Gene-editing is not the only application for #CRISPR technology. Dr @zhangf, a CRISPR pioneer and molecular biologi… https://t.co/r55OEPcK3k
— Leaps by Bayer (@LeapsByBayer) November 08, 2019
We’ve partnered with @eGenesisBio to accelerate their mission of providing solutions for the many millions of peopl… https://t.co/IQTbh85ybN
— Leaps by Bayer (@LeapsByBayer) November 08, 2019
We’ve partnered with @egenesis to accelerate their mission of providing solutions for the many thousands of people… https://t.co/BER3QA0Lq1
— Leaps by Bayer (@LeapsByBayer) November 07, 2019
Treatment for Parkinson’s disease can be strenuous, so it’s always good for #physicians to brush up on the key poin… https://t.co/PFF8Zlamo2
— BlueRock (@BlueRockTx) November 06, 2019
French company #Carbios says it will provide the world's first biological technology for the recycling of plastics.… https://t.co/GMQNP9HWQr
— Leaps by Bayer (@LeapsByBayer) November 06, 2019
We're proud to be a part of the @medopad mission to address intractable diseases by leveraging the power of #AI. https://t.co/ySYJY10YB3
— Leaps by Bayer (@LeapsByBayer) November 05, 2019
Animal meat consists mostly of skeletal muscle which grow in long, thin fibers and reproducing them is one of the b… https://t.co/t8yWWMFR7z
— Leaps by Bayer (@LeapsByBayer) November 05, 2019
This November (6-8) join @BlueRockTx in Toronto, Canada at the 2019 International Symposia of @ISSCR to learn about… https://t.co/tlx4FUMBQr
— BlueRock (@BlueRockTx) November 04, 2019
Macrophages are essential parts of our immune systems. But what exactly do they do? #TheMoreYouKnow https://t.co/T6YfjJwsuq
— BlueRock (@BlueRockTx) November 04, 2019
Have you heard about the current #quantumcomputing debate? The recent developments could one day impact how researc… https://t.co/v9WN6SfbVQ
— Leaps by Bayer (@LeapsByBayer) November 04, 2019
At #Hubweek19 we teamed up with #ImmersiveTech to create an escape game like no other. Teams were invited to experi… https://t.co/WNUKv8g6pK
— Leaps by Bayer (@LeapsByBayer) November 01, 2019
A fantastic effort from everyone who participated in #BreakingThroughImpossible - the escape game at #HubWeek2019,… https://t.co/OyqQ8ImVrf
— Leaps by Bayer (@LeapsByBayer) October 31, 2019
In a recent study, @catherinefreije and @cambearon of @broadinstitute found a potential way to adapt the ability to… https://t.co/IzjRE2kJga
— Leaps by Bayer (@LeapsByBayer) October 30, 2019
The 2019 @ISSCR International Symposia presents a slate of world-renowned experts from academia and industry--three… https://t.co/eNafta0V71
— BlueRock (@BlueRockTx) October 29, 2019
Exciting news for our most recent Joint Venture @PyxisOncology, as a new Chief Scientific Officer is appointed.… https://t.co/ObOGdjW80V
— Leaps by Bayer (@LeapsByBayer) October 29, 2019
Researchers at @UniversityLeeds have demonstrated a partnership between wheat and soil fungi that could be used to… https://t.co/jralBYJUAJ
— Leaps by Bayer (@LeapsByBayer) October 29, 2019
Approximately 120,000 people in the U.S. need a lifesaving organ transplant, and the demand cannot be met. Scientis… https://t.co/5Pzlp4Sb6r
— Leaps by Bayer (@LeapsByBayer) October 25, 2019
Tonight’s #LeapsTalk at @norrsken_org was truly fantastic. We are grateful to @JamieMetzl @Elainegrunewald and Max… https://t.co/rOit5MC0ks
— Leaps by Bayer (@LeapsByBayer) October 24, 2019
We are excited too https://t.co/tFMRd76BLi
— Leaps by Bayer (@LeapsByBayer) October 24, 2019
#CRISPR is a massively powerful yet still imperfect tool, and incremental biotechnologies to improve its accuracy a… https://t.co/ZJ19WPlGXy
— Leaps by Bayer (@LeapsByBayer) October 23, 2019
In three days time, our speakers will be in Stockholm to discuss how #biotech and #AI are transforming what being h… https://t.co/UZViDzA40V
— Leaps by Bayer (@LeapsByBayer) October 21, 2019
Our third #LeapsTalk in Stockolm with @Tegmark, @JamieMetzl and @ElaineGrunewald is sold out. Stay tuned for highli… https://t.co/Xfnpjfzof8
— Leaps by Bayer (@LeapsByBayer) October 18, 2019
BlueRockers Shane Kovacs and Eric Soller will be at the #xchangeNY on October 15 discussing the future of biotech i… https://t.co/eTrRlpGMSG
— BlueRock (@BlueRockTx) October 15, 2019
And finally Max @Tegmark. A physicist, cosmologist, professor at @MIT, and an expert in #AI. In his recent book Lif… https://t.co/g9L0frBCun
— Leaps by Bayer (@LeapsByBayer) October 15, 2019
Also joining us is @Elainegrunewald. A Tech for Good pioneer and Co-Founder of the @AISustCenter, an organisation d… https://t.co/AO8bhTpMdS
— Leaps by Bayer (@LeapsByBayer) October 15, 2019
Our first guest @jamiemetzl is a technology futurist and geopolitical expert. His compelling new book… https://t.co/GQZczc7iR5
— Leaps by Bayer (@LeapsByBayer) October 15, 2019
Next week in Stockholm alongside @norrsken_org, our guest speakers and experts will be tackling #geneediting and… https://t.co/VFz4dnkExr
— Leaps by Bayer (@LeapsByBayer) October 15, 2019
Our third #LeapsTalk, Hacking Humans, will be a unique conversation about #geneediting and #AI with three of the wo… https://t.co/5zJO6R63Yj
— Leaps by Bayer (@LeapsByBayer) October 14, 2019
The third edition of #LeapsTalk will take place on October 24th in Stockholm. We'll be joined by leading thinkers… https://t.co/VAACktrZb2
— Leaps by Bayer (@LeapsByBayer) October 10, 2019
What an excellent week in Boston. We brought the spirit of #biotech innovation and discovery to #HubWeek2019 with o… https://t.co/bnt2WxjEs7
— Leaps by Bayer (@LeapsByBayer) October 09, 2019
The International Society for Stem Cell Research is committed to showcasing leading-edge, contemporary and relevant… https://t.co/hR2faEDjWi
— BlueRock (@BlueRockTx) October 08, 2019
RT @HubWeek: This science-based escape game created by @LeapsByBayer was a major highlight of the #HubWeek2019 Fall Festival - so much fun…
— Leaps by Bayer (@LeapsByBayer) October 07, 2019
Thanks again to @ReshmaPShetty of @Ginkgo Bioworks, @kathleenkennedy of the MIT Center for Collective Intelligence,… https://t.co/V1rWRn3i59
— Leaps by Bayer (@LeapsByBayer) October 04, 2019
We can’t wait for our third #LeapsTalk, organized with our amazing partner @norrsken_org. Next stop, #Stockholm https://t.co/lRTt0uTCyC
— Leaps by Bayer (@LeapsByBayer) October 03, 2019
In our #LeapsTalk on #impactinvesting and #biotech at Boston @hubweek, @reshmapshetty shared advice to young entrep… https://t.co/zigyy2Hlid
— Leaps by Bayer (@LeapsByBayer) October 01, 2019
Our second edition of #LeapsTalk will take place at #HubWeek2019 today at 14:30. With Greg Shell of @BainCapital an… https://t.co/SwE9PUUkC9
— Leaps by Bayer (@LeapsByBayer) October 01, 2019
Just north of Boston in Cambridge, MA, you'll find @CasebiaTX. Using #CRISPR/Cas-9 #geneediting technology, they're… https://t.co/Fytj9qfEtF
— Leaps by Bayer (@LeapsByBayer) October 01, 2019
Also based in Boston are @PyxisOncology, a new JV whose work, based on new insights into the tumour microenvironmen… https://t.co/bjpIFyfSCR
— Leaps by Bayer (@LeapsByBayer) October 01, 2019
Founded alongside @Gingko, @JoynBio are harnessing soil microbes to address farmers' biggest challenges. Their main… https://t.co/ol7vRnpYp9
— Leaps by Bayer (@LeapsByBayer) October 01, 2019
Boston is home to some of the most innovative companies in #biotech, including one of our joint ventures! Here's an… https://t.co/RjOqtDlG6H
— Leaps by Bayer (@LeapsByBayer) October 01, 2019